Busan BGSS Eye Clinic · JCI-Accredited Ophthalmology Since 1997 · 7-Language Patient Care

JCI-Accredited · Since 1997

en-US

Busan BGSS Eye Clinic LogoHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsArticlesReviewsAbout UsContact Us
EVO+ ICL

ICL (Lens Implantation) · Needs Clinic Confirmation

EVO+ ICL

EVO+ ICL is a phakic lens implantation procedure in which a soft Collamer lens manufactured by STAAR Surgical is inserted between the iris and the natural crystalline lens.

Schedule a Consultation

What Is EVO+ ICL? Cornea-Preserving Lens Implant Vision Correction in Busan

STAAR Surgical EVO+ ICL collamer phakic intraocular lens resting on a clinician's fingertip.

EVO+ ICL is a phakic lens implantation procedure in which a soft Collamer lens manufactured by STAAR Surgical is inserted between the iris and the natural crystalline lens — correcting myopia without touching, cutting, or ablating the cornea. Unlike LASIK, SMILE, or LASEK, which reshape the corneal stroma to correct refractive error, EVO+ ICL leaves the cornea entirely intact. This makes it the primary vision correction option at Busan BGSS Eye Clinic in Seomyeon, Busanjin-gu for patients whose corneal thickness, curvature, or prescription places them outside the safe parameters for laser-based procedures.

The EVO+ generation introduces a significantly enlarged optical zone compared with previous ICL designs — up to 10% larger — providing safe vision correction for patients with larger pupils while minimizing night-time halos, glare, halo effect, and higher-order aberrations that were more pronounced in earlier lens generations. Central 360μm holes in the optical zone restore natural aqueous humor flow between the anterior and posterior chambers, eliminating the need for a separate pre-operative iridotomy procedure entirely. At the Seomyeon, Busanjin-gu clinic, EVO+ ICL is performed as a same-day bilateral procedure — both eyes corrected in a single visit — compared with conventional ICL protocols that required a minimum of four visits over one week.

Who Is a Candidate for EVO+ ICL Vision Correction in Busan?

EVO+ ICL at Busan BGSS Eye Clinic in Seomyeon is designed for patients who want clear, stable vision correction but are not suitable for laser-based procedures — or who want a cornea-preserving, reversible alternative regardless of laser eligibility. Our team at the Busanjin-gu, Busan clinic conducts comprehensive pre-operative diagnostics including anterior chamber depth measurement, corneal topography, and refraction to confirm suitability before any procedure is planned.

Ideal candidates for EVO+ ICL at the Seomyeon clinic include:

  • Patients with high or extreme myopia beyond the safe correction range of LASIK, SMILE, or LASEK — EVO+ ICL corrects prescriptions that laser procedures cannot safely address at the Busan facility

  • Those with very thin corneas for whom any corneal ablation would leave insufficient residual thickness — ICL implantation preserves the cornea entirely

  • Patients for whom laser vision correction is not possible due to irregular corneal topography, borderline keratoconus risk, or other contraindications to surface or stromal ablation at the Seomyeon, Busanjin-gu clinic

  • Working professionals and students who cannot take extended leave — the same-day bilateral surgery protocol at the Busan BGSS clinic reduces the total procedure timeline to two days minimum, compared with one week or more for conventional ICL

  • Patients with larger pupils concerned about night-time halos and glare after vision correction — the EVO+ enlarged optical zone specifically addresses this concern

  • Dry eye-prone patients — EVO+ ICL does not disrupt corneal nerves or alter the tear film, making it the preferred option over laser correction for patients with existing dry eye conditions at the Seomyeon facility

  • International patients traveling to Busan who need a defined, efficient surgical pathway — same-day bilateral surgery minimizes the number of visits required and simplifies post-surgical travel planning

Patients with insufficient anterior chamber depth, active ocular disease, unstable myopia, or other anatomical contraindications are not suitable for EVO+ ICL. Our team at the Busanjin-gu, Busan clinic evaluates every patient individually and recommends the most appropriate refractive pathway.

Our Team at Busan BGSS Eye Clinic, Seomyeon

EVO+ ICL at Busan BGSS Eye Clinic is performed and managed by our team of five senior directors, each holding concurrent academic appointments at major regional universities in Busan. The Seomyeon, Busanjin-gu clinic's refractive and lens surgery program is led by directors whose combined expertise spans cataract surgery, corneal disease, refractive procedures, retinal care, glaucoma, and oculoplastics — providing the full clinical depth required to evaluate, plan, and follow up complex ICL cases.

Our team's approach to EVO+ ICL reflects a consistent clinical philosophy: precise anterior segment assessment, patient-specific lens sizing and power calculation, same-day bilateral surgical efficiency, and post-operative outcome monitoring grounded in published clinical data. Busan BGSS Eye Clinic was designated the Asia-Pacific Regional Center for EVO ICL Training in 2026 — a recognition that reflects not only the volume and quality of ICL procedures performed at the Seomyeon facility, but the team's role in advancing ICL surgical standards across the region.

The BGSS network's founding director has served as a keynote presenter at international ICL conferences, contributing to the global development of EVO ICL surgical technique and outcomes research — expertise and institutional knowledge that directly inform the ICL program at the Seomyeon, Busanjin-gu clinic.

EVO+ ICL Treatment Areas and Expected Vision Improvements

  • High and Extreme Myopia Correction: EVO+ ICL at the Seomyeon, Busanjin-gu clinic corrects refractive error by adding a precisely powered Collamer lens to the eye's optical system — without removing any corneal tissue. This approach is particularly effective for high and extreme myopia, where the depth of correction required would either exceed safe laser ablation limits or leave insufficient residual corneal thickness for long-term stability. Our team at the Busanjin-gu, Busan facility calculates each lens's power and dimensions based on individual anterior chamber measurements, ensuring a customized fit for every patient.

  • Enlarged Optical Zone and Night Vision Quality: The EVO+ optical zone — up to 10% larger than previous ICL generations — provides clear, stable vision correction across a wider pupil diameter. At the Seomyeon clinic, this is particularly meaningful for patients with naturally large pupils, who are most susceptible to the night-time halos, glare, and halo effects associated with smaller optical zone implants. The enlarged optical zone also supports improved correction of higher-order aberrations, contributing to the 94% quality of vision satisfaction rate reported in STAAR Surgical's 3,500-patient data.

  • Corneal Preservation and Long-Term Stability: Because EVO+ ICL at the Busanjin-gu, Busan clinic does not ablate, reshape, or structurally alter the cornea, patients retain full corneal integrity after surgery. This eliminates the risk of corneal flap complications, ectasia, or structural weakening associated with laser procedures — and preserves the option for future corneal-based correction if clinical needs change. The near-zero myopic regression profile of ICL, combined with the reversibility of the implant, makes EVO+ ICL the most stable long-term refractive option available at the Seomyeon facility for eligible patients. Results vary by individual and no specific outcome is guaranteed.

EVO+ ICL Procedure Steps and Recovery Timeline at Busan BGSS Eye Clinic

Patient undergoing pre-operative diagnostic eye imaging and anterior chamber evaluation for EVO+ ICL surgery.

EVO+ ICL at Busan BGSS Eye Clinic in Seomyeon, Busanjin-gu is performed under topical and/or local anaesthetic and completed efficiently for both eyes in a single visit. The full pathway:

  1. Pre-Operative Diagnostics and Lens Sizing — Our team conducts comprehensive anterior chamber depth measurement, corneal topography, refraction, pupil size mapping, and endothelial cell count at the Seomyeon clinic. These measurements determine the precise EVO+ lens power, size, and surgical approach for each eye, and confirm that anterior chamber dimensions are suitable for safe implantation.

  2. Same-Day Bilateral Surgery — First Eye — Under anaesthetic drops, our surgeon creates a small corneal incision and inserts the folded EVO+ ICL into the anterior chamber at the Busanjin-gu, Busan facility. The lens unfolds and is positioned between the iris and the natural crystalline lens. The central 360μm holes in the optical zone immediately allow natural aqueous humor flow — no iridotomy required. The corneal incision is self-sealing and requires no sutures.

  3. Same-Day Bilateral Surgery — Second Eye — Both eyes are treated in the same surgical session at the Seomyeon, Busanjin-gu clinic, eliminating the need for a separate return visit for the second eye. This same-day bilateral approach — enabled by our team's proprietary surgical protocol — reduces the total procedure from four visits over one week to a minimum of two visits over two days.

  4. Immediate Post-Operative Assessment — Following both implantations, our team at the Busan BGSS clinic reviews lens position, intraocular pressure, and early visual function before the patient is discharged with prescribed anti-inflammatory and antibiotic eye drops and detailed aftercare instructions.

  5. Next-Day Follow-Up — A follow-up appointment at the Seomyeon, Busanjin-gu clinic the day after surgery assesses lens centration, intraocular pressure, corneal clarity, and uncorrected visual acuity. Most patients notice significant vision improvement from this first review.

  6. Ongoing Stabilization and Monitoring — Visual acuity continues to stabilize over the following weeks. Our team schedules follow-up visits at the Busanjin-gu, Busan clinic to monitor lens position, endothelial cell health, and refractive stability — ensuring the long-term safety and performance of the EVO+ implant.

EVO+ ICL Results, Safety, and Longevity

EVO+ ICL is supported by extensive clinical evidence. STAAR Surgical's survey of 3,500 ICL patients shows 99% overall satisfaction, 97% who would choose the same surgery again, and 94% satisfied with their quality of vision — outcome metrics that position EVO+ ICL among the highest-rated elective vision correction procedures available. At Busan BGSS Eye Clinic in Seomyeon, Busanjin-gu, these results are supported by our team's dedicated ICL program, including the Asia-Pacific Regional Center for EVO ICL Training designation awarded in 2026. Results vary by individual and no specific outcome is guaranteed.

The safety profile of EVO+ ICL at the Seomyeon clinic is reinforced by its cornea-preserving design — no ablation means no risk of corneal ectasia, flap complications, or structural weakening. The iridotomy-free central hole design eliminates a pre-operative surgical step and the associated recovery it previously required. The Collamer lens material is biocompatible and UV-blocking. Potential side effects include temporary light sensitivity, mild halos during the early healing period, and transient intraocular pressure fluctuation. Serious complications are uncommon and our team's thorough pre-operative screening at the Busanjin-gu, Busan facility minimizes risk further. If complications do arise, the lens can be removed and the eye returned to its pre-surgical state.

EVO+ ICL provides stable, long-term vision correction with near-zero myopic regression — a significant advantage over laser procedures in higher prescriptions. The implant does not degrade over time under normal conditions. Age-related changes to the natural crystalline lens, such as presbyopia or cataract development, occur independently and are not affected by the presence of the ICL. Our team discusses realistic long-term expectations with every patient at the pre-operative consultation.

Why Choose Busan BGSS Eye Clinic in Seomyeon for EVO+ ICL?

Private consultation room at the International Healthcare Center in Busan BGSS Eye Clinic, Seomyeon.

Busan BGSS Eye Clinic, located in Seomyeon, Busanjin-gu, Busan, was designated the Asia-Pacific Regional Center for EVO ICL Training in 2026 — a formal recognition of the Seomyeon clinic's role as a regional leader in ICL surgical standards, volume, and outcomes. Our team of five senior directors, each holding university appointments at major Busan medical institutions, brings the anterior segment expertise, surgical precision, and clinical depth that EVO+ ICL demands. The same-day bilateral surgery protocol — reducing the conventional four-visit, one-week ICL timeline to a minimum of two visits over two days — reflects the proprietary surgical efficiency developed through decades of ICL practice at the Busanjin-gu, Busan facility. As the founding BGSS location since 1997 with 330,000+ vision correction surgeries performed, the Seomyeon clinic's credentials speak clearly:

  • First ophthalmology clinic in Korea to receive JCI accreditation — four cycles

  • Asia-Pacific Regional Center for EVO ICL Training (2026) and Advanced Regenerative Medicine Institution (2026)

  • Key Medical Tourism Cooperative Institution, City of Busan — multilingual support in Chinese, English, Japanese, Mongolian, Russian, Vietnamese, and Indonesian

  • Same-day bilateral ICL surgery — both eyes corrected in one visit, minimum two-day total pathway at the Seomyeon, Busanjin-gu clinic

  • 330,000+ vision correction surgeries since 1997 — highest volume across the BGSS network

Patient Experiences: EVO+ ICL at Busan BGSS Eye Clinic, Seomyeon

Patient Vignette 1 — Extreme Myopia, Early 30s

A patient in their early 30s traveling to Busan had been told by multiple clinics that their prescription was too high for LASIK or SMILE. Following anterior chamber assessment at the Seomyeon, Busanjin-gu clinic, our team confirmed EVO+ ICL as the appropriate pathway. Both eyes were treated in a single surgical session, and the patient achieved clear functional vision at the next-day review without corneal ablation or structural alteration. Results vary; no outcome is guaranteed.

Patient Vignette 2 — Thin Corneas, Working Professional, Late 20s

A patient in their late 20s at the Busanjin-gu, Busan clinic had thin corneas that placed them outside safe LASIK parameters and could not take extended leave for a multi-visit procedure. The same-day bilateral EVO+ ICL protocol at the Seomyeon clinic required only two visits total. The patient returned to work two days after surgery with significantly improved uncorrected vision and no dry eye symptoms. Individual results vary and no specific outcome is guaranteed.

See Clearly Without Laser — Book Your EVO+ ICL Consultation in Busan

If high myopia, thin corneas, or unsuitability for laser correction has kept you from achieving clear vision, our team at Busan BGSS Eye Clinic in Seomyeon, Busanjin-gu is ready to evaluate whether EVO+ ICL is the right option for your eyes. As the Asia-Pacific Regional Center for EVO ICL Training, with 330,000+ vision correction surgeries since 1997, JCI accreditation, and a same-day bilateral surgery protocol that minimizes your time away from daily life, the Seomyeon clinic offers the ICL expertise and institutional depth that complex refractive cases require. International patients are fully supported from consultation through post-operative follow-up in Chinese, English, Japanese, Mongolian, Russian, Vietnamese, and Indonesian.

**[Book Your Free EVO+ ICL Consultation at Busan BGSS Eye Clinic](/contact-us)

Other Services

Explore our comprehensive range of healthcare offerings tailored to your needs.

View All
Dry Eye Diagnostic Testing

Dry Eye Diagnostic Testing

It is a spectrum of disorders with distinct underlying mechanisms — each requiring a different clinical response.

Learn More

Learn More
Aqua IPL / Aqua Lifting

Aqua IPL / Aqua Lifting

Dry eye syndrome is one of the most common and undertreated conditions in ophthalmology — affecting contact lens wearers, digital screen users, post-surgical patients, and adults over 40 with progressively declining tear film quality.

Learn More

Learn More
Autologous Serum Eye Drops

Autologous Serum Eye Drops

Autologous serum eye drops are a specialized therapeutic preparation in which a patient's own blood is processed to extract the serum — which is then formulated as personalized eye drops.

Learn More

Learn More

Busan BGSS Eye Clinic

JCI-accredited ophthalmology clinic in Seomyeon, Busan since 1997, specializing in SMILE Pro, SMILE LASIK, EVO ICL, presbyopia & cataract surgery with 7-language international care.

Treatments

SpecialtiesServicesMedical TeamMedical Articles

Patient Guide

About UsHow It WorksPatient Reviews

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© 2026 Busan BGSS Eye Clinic. All rights reserved.

All procedures and surgical outcomes vary based on individual ocular examination findings. Consult an ophthalmologist for personalized medical advice.